Advertisement

Topics

BRIEF—ICER to review erenumab and revist plaque psoriasis therapies

11:06 EST 10 Nov 2017 | thePharmaLetter

The Institute for Clinical and Economic Review (ICER), the highly-referenced Boston, USA-based research…

Original Article: BRIEF—ICER to review erenumab and revist plaque psoriasis therapies

NEXT ARTICLE

More From BioPortfolio on "BRIEF—ICER to review erenumab and revist plaque psoriasis therapies"

Advertisement
Quick Search
Advertisement
Advertisement